Get startedLog in
    Picture of Quantum Cyber NV logo

    QUCY — Quantum Cyber NV News Story

    0.000.00%
    us flag iconLast trade - 00:00
    TechnologySpeculativeSmall CapNeutral
    All News

    Brief: Mainz Biomed NV- Reconaasense Designed To Evaluate Gold Standard At-Home Colorectal Cancer Screening Test, On Track To Commence Enrollment In Mid-2024

    Picture of Quantum Cyber NV logoQuantum Cyber NV
    09/01/2024 14:24
    Jan 9 (Reuters) - Mainz Biomed NV  4TO.F :
    * MAINZ BIOMED NV- RECONAASENSE DESIGNED TO EVALUATE GOLD
STANDARD
AT-HOME COLORECTAL CANCER SCREENING TEST, ON TRACK TO COMMENCE
ENROLLMENT IN MID-2024

Source text for Eikon:  ID:nGNX1dfMg0 
Further company coverage:  4TO.F 

 (Reporting by Vallari Srivastava)
 ((Srivastava.Vallari@thomsonreuters.com;))

    Recent news on Quantum Cyber NV

    See all news